Company Management will be presenting and holding one-on-one meetings with investors at Jefferies 2017 London Healthcare Conference Date & Time: 15…
Month: November 2017
Q3 Report 2017
ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update
– All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months – Geneva, Switzerland and Boston, MA – November 14,…
Q3 2017 ObsEva SA Earnings Conference call
ObsEva to report financial results and business update for the third quarter on Tuesday, November 14, 2017 Date & Time: 14…
ObsEva at Credit Suisse Healthcare Conference
Company Management will be presenting and holding one-on-one meetings with investors at Credit Suisse Healthcare Conference Date & Time: 8 November…
ObsEva SA Announces the Completion of Patient Recruitment in the EDELWEISS Phase 2b Clinical Trial of OBE2109 for the Treatment of Endometriosis
Geneva, Switzerland and Boston, MA – November 7, 2017 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for…